The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, function, and interactions. Proteomics plays a critical role in understanding ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...

Improving accessibility, affordability, and tailoring treatment and diagnostics to women's needs are some of the crucial measures to closing the health gap for the fairer sex by 2030, said experts at ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by ...

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...